Advertisement

Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus

Sponsored by GlaxoSmithKline

Phase Quota
Phase 4

Albiglutide is an analogue of glucagon-like peptide-1 (GLP-1), used to treat type 2 diabetes This study will test whether albiglutide affects the occurrence of major cardiovascular events such as heart attacks or strokes and other important medical outcomes in persons with type 2 diabetes, when used alone or added to other diabetes treatments.

Study Start Date: July 2015

Estimated Completion Date: May 2019

Specialties: Internal Medicine: Cardiology,Clinical Pharmacology,Endocrinology,Vascular Medicine Nursing: Endocrinology Endocrinology: Diabetes,Pharmacology/kinetics Physician Assistant: Endocrinology

Interventions

  • Biological: Albiglutide matching placebo
  • Biological: Albiglutide 30 mg
  • Biological: Albiglutide 50 mg

Inclusion criteria

  • Men or women at least 40 years old. Women must be post-menopausal or using a highly effective method for avoidance of pregnancy
  • Diagnosis of type 2 diabetes
  • Established cardiovascular disease with at least one of the following: coronary artery disease, cerebrovascular disease, or peripheral arterial disease
  • HbA1c >7.0% (53 mmol/mol) (based on the most recent documented laboratory measurement within 6 months)
  • Able and willing to provide informed consent

Exclusion criteria

  • Severely reduced kidney function: eGFR
  • Use of a GLP-1 receptor agonist at Screening
  • Severe gastroparesis
  • History of pancreatitis or considered clinically at significant risk of developing pancreatitis during the course of the study
  • Personal or family history of medullary carcinoma of the thyroid or subject with multiple endocrine neoplasia type 2 (MEN-2). Personal history of pancreatic neuroendocrine tumours
  • Medical history which might limit the subject's ability to take trial treatments for the duration of the study or to otherwise complete the study
  • Breastfeeding, pregnancy, or planning a pregnancy during the course of the study. Note: a pregnancy test will be performed on all women of child bearing potential prior to study entry
  • Known allergy to any GLP-1 receptor agonist or excipients of albiglutide
  • Use of another investigational product within 30 days or according to local regulations, or currently enrolled in a study of an investigational device
  • Any other reason the investigator deems the subject to be unsuitable for the study

Study Locations And Contact Information

  • GSK Investigational Site, Mobile Alabama
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Simi Valley California
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Belle Glade Florida
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Bradenton Florida
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Coral Springs Florida
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Fleming Island Florida
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, San Diego California
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Inverness Florida
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Jacksonville Florida
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Lake Worth Florida
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Ocala Florida
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Port Charlotte Florida
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Port Orange Florida
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Vero Beach Florida
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Atlanta Georgia
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Decatur Georgia
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Champaign Illinois
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Avon Indiana
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Greenfield Indiana
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Muncie Indiana
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Des Moines Iowa
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Auburn Maine
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Tempe Arizona
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Tucson Arizona
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Little Rock Arkansas
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Searcy Arkansas
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Chula Vista California
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Lomita California
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Omaha Nebraska
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Camden New Jersey
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Alpena Michigan
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Kalamazoo Michigan
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, North Massapequa New York
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Charlotte North Carolina
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Buenos Aires
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Buenos Aires
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Buenos Aires
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Ciudad Autonoma de Buenos Aires
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Ciudad Autonoma de Buenos Aires
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Ciudad Autonoma de Buenos Aires
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Ciudad Autónoma de Buenos Aires
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, La Plata
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Mendoza
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Santa Fe
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Bonheiden
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Brussels
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Bruxelles
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Edegem
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Leuven
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Liège
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Roeselare
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Byala
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Gabrovo
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Montana
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Sevlievo
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Sofia
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Sofia
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Sofia
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Stara Zagora
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Kelowna British Columbia
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Surrey British Columbia
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Victoria British Columbia
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Winnipeg Manitoba
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Moncton New Brunswick
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, St. John's Newfoundland and Labrador
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Halifax Nova Scotia
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Cambridge Ontario
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Hamilton Ontario
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, London Ontario
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Sudbury Ontario
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Greenfield Park Quebec
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Wilmington North Carolina
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Fargo North Dakota
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Cleveland Ohio
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Sandusky Ohio
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Camp Hill Pennsylvania
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Jersey Shore Pennsylvania
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Penndel Pennsylvania
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Statesville North Carolina
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Anderson South Carolina
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Columbia South Carolina
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Rapid City South Dakota
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Bristol Tennessee
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Memphis Tennessee
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Nashville Tennessee
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Nashville Tennessee
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Austin Texas
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Dallas Texas
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, El Paso Texas
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Ciudad Autonoma de Buenos Aires Buenos Aires
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Mar del Plata Buenos Aires
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Mar del Plata Buenos Aires
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Pergamino Buenos Aires
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Godoy Cruz Mendoza
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, San Rafael Mendoza
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Rosario Santa Fe
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Rosario Santa Fe
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Berazategui
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Buenos Aires
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Buenos Aires
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Ciudad Autonoma de Buenos Aires Buenos Aires
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, St-Charles-Borromée Quebec
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Beroun
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Krnov
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Ostrava
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Praha 10
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Praha 1
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Praha 2
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Praha 4
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Praha 5
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Pribram 1
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Usti nad Labem
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Zlin
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Copenhagen
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Hellerup
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Herlev
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Esbjerg
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Frederikssund
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Holbæk
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Hvidovre
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, København NV
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, København S
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Roskilde
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Amiens Cedex 1
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Brest cedex
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Broglie
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Corbeil-Essonnes
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, La Rochelle Cedex 1
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Nantes cedex 2
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Narbonne Cedex
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Paris
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Pau Cedex
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Pierre-Bénite Cedex
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Strasbourg cedex
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Vandoeuvre-lès-Nancy
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Deggingen Baden-Wuerttemberg
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Kingwood Texas
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Palestine Texas
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Manassas Virginia
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Tacoma Washington
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Adrogue Buenos Aires
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Ciudad Autonoma de Buenos Aires Buenos Aires
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Riesa Sachsen
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Berlin
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Berlin
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Berlin
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Berlin
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Berlin
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Dortmund
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Hamburg
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Hamburg
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Hamburg
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Mannheim
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Pirna
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Alexandroupolis
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Athens,
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Athens
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Athens
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Haidari, Athens
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Heraklion, Crete
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Ioannina
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Nikaia Piraeus
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Pireas
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Thessaloniki
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Thessaloniki
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Thessaloniki
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Thessaloniki
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Thessaloniki
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Hong Kong
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Shatin
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Budapest
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Budapest
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Debrecen
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Debrecen
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Eger
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, GödöllÅ?
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Hatvan
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Komarom
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Miskolc
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Sátoraljaújhely
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Napoli Campania
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Napoli Campania
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Bologna Emilia-Romagna
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Ravenna Emilia-Romagna
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Roma Lazio
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Milano Lombardia
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Milano Lombardia
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Vigevano (PV) Lombardia
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Ancona Marche
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, San Giovanni Rotondo (FG) Puglia
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, S.Andrea delle Fratte - S. Sisto (PG) Umbria
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Padova Veneto
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Gyeonggi-do
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Gyeonggido
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Parma Emilia-Romagna
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Kangwondo
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Poznan
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Poznan
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Warszawa
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Wierzchoslawice
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Wroclaw
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Wroclaw
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Arkhangelsk
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Barnaul
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Chelyabinsk
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Chelyabinsk
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Ekaterinburg
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Ekaterinburg
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Ivanovo
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Kemerovo
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Kemerovo
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Krasnodar
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Moscow
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Moscow
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Seoul
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Seoul
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Pusan
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Seoul
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Seoul
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Seoul
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Seoul
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Seoul
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Seoul
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Seoul
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Suwon, Kyonggi-do
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Suwon
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Guadalajara Jalisco
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Monterrey NL Nuevo León
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Monterrey Nuevo León
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Aguascalientes
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Querétaro
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Alkmaar
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Eindhoven
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Gouda
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Hardenberg
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Heerlen
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Hoogeveen
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Meppel
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Sneek
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Hoenefoss
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Kolbjørnsvik
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Stavanger
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Callao Lima
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, San Martin de Porres Lima
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Arequipa
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Lima
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Lima
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Lima
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Lima
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Lima
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Lima
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Bialystok
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Bydgoszcz
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Bydgoszcz
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Gdansk
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Gniewkowo
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Katowice
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Krakow
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Krakow
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Oslo
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Lublin
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Oslo
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Stuttgart Baden-Wuerttemberg
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Wangen Baden-Wuerttemberg
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Aschaffenburg Bayern
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Dachau Bayern
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Haag Bayern
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Kuenzing Bayern
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Muenchen Bayern
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Rednitzhembach Bayern
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Wallerfing Bayern
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Potsdam Brandenburg
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Hildesheim Niedersachsen
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Stuhr Niedersachsen
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Bochum Nordrhein-Westfalen
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Essen Nordrhein-Westfalen
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Kleve Nordrhein-Westfalen
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Muenster Nordrhein-Westfalen
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Witten Nordrhein-Westfalen
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Ludwigshafen am Rhein Rheinland-Pfalz
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Hohenmoelsen Sachsen-Anhalt
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Chemnitz Sachsen
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Dresden Sachsen
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Leipzig Sachsen
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Moscow
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Moscow
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Moscow
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Nizhniy Novgorod
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Nizhny Novgorod
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Novosibirsk
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Novosibirsk
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Perm
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Rostov-on-Don
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Ryazan
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Saint Petersburg
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Samara
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Saratov
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Tomsk
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Tomsk
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Tomsk
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Voronezh
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Yaroslavl
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Yaroslavl
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Yaroslavl
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Yaroslavl
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Alicante
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Almeria
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Alzira/Valencia
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Badalona
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Barcelona
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Barcelona
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Barcelona
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Barcelona
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Boadilla del Monte (Madrid)
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Canet de Mar - Barcelona
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Moscow
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Cangas del Narcea/Asturias
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Centelles (Barcelona)
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Córdoba
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Elche
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Getafe/Madrid
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Granada
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, La Coruña
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, León
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Madrid
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Madrid
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Madrid
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Madrid
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Madrid
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Madrid
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Malaga
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Málaga
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Palma de Mallorca
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Palma de Mallorca
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Pontevedra
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Pozuelo de Alarcón/Madrid
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Sagunto/Valencia
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, San Juan (Alicante)
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Sanlucar de Barrameda - Cádiz
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Santiago de Compostela
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Sevilla
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Sta Coloma de Gramanet (Barcelona)
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Valencia
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Valencia
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, BorÃ¥s
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Eksjö
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Helsingborg
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Härnösand
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Karlskrona
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Kristianstad
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Linköping
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Ljungby
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Malmö
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Rättvik
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Stockholm
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Stockholm
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, UmeÃ¥
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Uppsala
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Ã?rebro
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Changhua
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Hualien
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Kaohsiung
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Taichung
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Tainan
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Taipei
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Chernivtsi
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Dnipropetrovsk
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Kharkiv
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Kharkiv
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Kherson
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Kyiv
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Kyiv
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Kyiv
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Kyiv
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Kyiv
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Kyiv
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Mykolaiv
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Odesa
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Poltava
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Uzhgorod
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Vinnytsia
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Göteborg
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Zaporizhzhya
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Soham Cambridgeshire
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Edinburgh Midlothian
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Aberdeen
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Axbridge, Somerset
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Blackpool
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Bristol
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Dumfries
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Dundee
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Dundee
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Dundee
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Fife
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Fife
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Gloucester
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Lancaster
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Manchester
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Oxford
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Rotherham
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Wigan
    Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
  • GSK Investigational Site, Fargo North Dakota
  • GSK Investigational Site, Leipzig Sachsen
  • GSK Investigational Site, Witten Nordrhein-Westfalen
  • GSK Investigational Site, Inverness Florida
  • GSK Investigational Site, Pribram 1
  • GSK Investigational Site, Tlaquepaque Jalisco
  • GSK Investigational Site, Canet de Mar - Barcelona
  • GSK Investigational Site, Chemnitz Sachsen
  • GSK Investigational Site, Dresden Sachsen
  • GSK Investigational Site, Alexandroupolis
  • GSK Investigational Site, Ljungby
  • GSK Investigational Site, Pau Cedex
  • GSK Investigational Site, Uppsala
  • GSK Investigational Site, Siena Toscana
  • GSK Investigational Site, Oslo
  • GSK Investigational Site, Rapid City South Dakota
  • GSK Investigational Site, Milano Lombardia
  • GSK Investigational Site, Chemnitz
  • GSK Investigational Site, Mobile Alabama
  • GSK Investigational Site, Mendoza
  • GSK Investigational Site, Nizhniy Novgorod
  • GSK Investigational Site, London Ontario
  • GSK Investigational Site, Pierre-Bénite Cedex
  • GSK Investigational Site, Lake Worth Florida
  • GSK Investigational Site, Dallas Texas
  • GSK Investigational Site, Padova Veneto
  • GSK Investigational Site, Essen Nordrhein-Westfalen
  • GSK Investigational Site, Nashville Tennessee
  • GSK Investigational Site, Guadalajara Jalisco
  • GSK Investigational Site, Arkhangelsk
  • GSK Investigational Site, Valencia
  • GSK Investigational Site, Budapest
  • GSK Investigational Site, Buenos Aires
  • GSK Investigational Site, Hamilton Ontario
  • GSK Investigational Site, Kristianstad
  • GSK Investigational Site, Lancaster
  • GSK Investigational Site, Wardenburg Niedersachsen
  • GSK Investigational Site, Weinheim Baden-Wuerttemberg
  • GSK Investigational Site, Stockholm
  • GSK Investigational Site, Heerlen
  • GSK Investigational Site, North Massapequa New York
  • GSK Investigational Site, Littleton Colorado
  • GSK Investigational Site, Poznan
  • GSK Investigational Site, Hildesheim Niedersachsen
  • GSK Investigational Site, Ciudad Autonoma de Buenos Aires
  • GSK Investigational Site, Riesa Sachsen
  • GSK Investigational Site, Bristol Tennessee
  • GSK Investigational Site, Amiens Cedex 1
  • GSK Investigational Site, Palma de Mallorca
  • GSK Investigational Site, Lima
  • GSK Investigational Site, Saint Petersburg
  • GSK Investigational Site, Dortmund
  • GSK Investigational Site, Thessaloniki
  • GSK Investigational Site, Krakow
  • GSK Investigational Site, Seoul
  • GSK Investigational Site, Praha 5
  • GSK Investigational Site, Kemerovo
  • GSK Investigational Site, Victoria British Columbia
  • GSK Investigational Site, Wallerfing Bayern
  • GSK Investigational Site, Madrid
  • GSK Investigational Site, Valencia
  • GSK Investigational Site, Krakow
  • GSK Investigational Site, Delitzsch Sachsen
  • GSK Investigational Site, Parma Emilia-Romagna
  • GSK Investigational Site, Floersheim Hessen
  • GSK Investigational Site, Chelyabinsk
  • GSK Investigational Site, Alicante
  • GSK Investigational Site, Praha 2
  • GSK Investigational Site, León
  • GSK Investigational Site, Essen Nordrhein-Westfalen
  • GSK Investigational Site, Odesa
  • GSK Investigational Site, Praha 1
  • GSK Investigational Site, Frederiksberg
  • GSK Investigational Site, Oxford
  • GSK Investigational Site, San Giovanni Rotondo (FG) Puglia
  • GSK Investigational Site, Lublin
  • GSK Investigational Site, Chicoutimi Quebec
  • GSK Investigational Site, Laval Quebec
  • GSK Investigational Site, Hohenmoelsen Sachsen-Anhalt
  • GSK Investigational Site, Athens
  • GSK Investigational Site, Ã?rebro
  • GSK Investigational Site, Long Beach California
  • GSK Investigational Site, Charlotte North Carolina
  • GSK Investigational Site, Pontevedra
  • GSK Investigational Site, Bochum Nordrhein-Westfalen
  • GSK Investigational Site, Bologna Emilia-Romagna
  • GSK Investigational Site, Warszawa
  • GSK Investigational Site, Lima
  • GSK Investigational Site, Holbæk
  • GSK Investigational Site, Kangwondo
  • GSK Investigational Site, Camp Hill Pennsylvania
  • GSK Investigational Site, Brest cedex
  • GSK Investigational Site, Muenchen Bayern
  • GSK Investigational Site, Goodyear Arizona
  • GSK Investigational Site, Hoenefoss
  • GSK Investigational Site, Sankt Ingbert Saarland
  • GSK Investigational Site, Krasnodar
  • GSK Investigational Site, Gyeonggido
  • GSK Investigational Site, San Antonio Texas
  • GSK Investigational Site, Petrer - Alicante Valencian Community
  • GSK Investigational Site, Simi Valley California
  • GSK Investigational Site, Mainz Rheinland-Pfalz
  • GSK Investigational Site, Wroclaw
  • GSK Investigational Site, San Sebastián de los Reyes/Madrid
  • GSK Investigational Site, Tomsk
  • GSK Investigational Site, Centelles (Barcelona)
  • GSK Investigational Site, Champaign Illinois
  • GSK Investigational Site, Greenfield Park Quebec
  • GSK Investigational Site, Sofia
  • GSK Investigational Site, Budapest
  • GSK Investigational Site, Kharkiv
  • GSK Investigational Site, Broglie
  • GSK Investigational Site, Wierzchoslawice
  • GSK Investigational Site, Bonheiden
  • GSK Investigational Site, Austin Texas
  • GSK Investigational Site, Sherbrooke Quebec
  • GSK Investigational Site, Pergamino Buenos Aires
  • GSK Investigational Site, Manassas Virginia
  • GSK Investigational Site, Hatvan
  • GSK Investigational Site, Weinheim Baden-Wuerttemberg
  • GSK Investigational Site, Harleysville Pennsylvania
  • GSK Investigational Site, Eindhoven
  • GSK Investigational Site, Winnipeg Manitoba
  • GSK Investigational Site, Badalona
  • GSK Investigational Site, Madrid
  • GSK Investigational Site, Usti nad Labem
  • GSK Investigational Site, Yaroslavl
  • GSK Investigational Site, Rosario Santa Fe
  • GSK Investigational Site, Georgetown Texas
  • GSK Investigational Site, La Plata
  • GSK Investigational Site, Kuenzing Bayern
  • GSK Investigational Site, Beroun
  • GSK Investigational Site, Rosario Santa Fe
  • GSK Investigational Site, Thessaloniki
  • GSK Investigational Site, Athens
  • GSK Investigational Site, Corbeil-Essonnes
  • GSK Investigational Site, Franklin Indiana
  • GSK Investigational Site, Thessaloniki
  • GSK Investigational Site, Gdansk
  • GSK Investigational Site, Coral Springs Florida
  • GSK Investigational Site, Kharkiv
  • GSK Investigational Site, Sanlucar de Barrameda - Cádiz
  • GSK Investigational Site, Novosibirsk
  • GSK Investigational Site, Wroclaw
  • GSK Investigational Site, Barcelona
  • GSK Investigational Site, Cornwall Ontario
  • GSK Investigational Site, Auburn Maine
  • GSK Investigational Site, Suwon, Kyonggi-do
  • GSK Investigational Site, Pirna
  • GSK Investigational Site, Ostrava
  • GSK Investigational Site, Valencia
  • GSK Investigational Site, Stavanger
  • GSK Investigational Site, Trois-Rivieres Quebec
  • GSK Investigational Site, Conyers Georgia
  • GSK Investigational Site, Alzira/Valencia
  • GSK Investigational Site, Aguascalientes
  • GSK Investigational Site, La Coruña
  • GSK Investigational Site, Milano Lombardia
  • GSK Investigational Site, Cleveland Ohio
  • GSK Investigational Site, Málaga
  • GSK Investigational Site, Nizhny Novgorod
  • GSK Investigational Site, Sagunto/Valencia
  • GSK Investigational Site, Córdoba Córdova
  • GSK Investigational Site, Praha 4
  • GSK Investigational Site, Portland Oregon
  • GSK Investigational Site, Moncton New Brunswick
  • GSK Investigational Site, Barcelona
  • GSK Investigational Site, Roskilde
  • GSK Investigational Site, Moscow
  • GSK Investigational Site, Barcelona
  • GSK Investigational Site, Surrey British Columbia
  • GSK Investigational Site, Nantes cedex 2
  • GSK Investigational Site, Linköping
  • GSK Investigational Site, Milano Lombardia
  • GSK Investigational Site, Sevlievo
  • GSK Investigational Site, Koeln Nordrhein-Westfalen
  • GSK Investigational Site, Eksjö
  • GSK Investigational Site, Plano Texas
  • GSK Investigational Site, Barnaul
  • GSK Investigational Site, Zaporizhzhya
  • GSK Investigational Site, Debrecen
  • GSK Investigational Site, Bristol
  • GSK Investigational Site, Rednitzhembach Bayern
  • GSK Investigational Site, Kelowna British Columbia
  • GSK Investigational Site, Littleton Colorado
  • GSK Investigational Site, Hoogeveen
  • GSK Investigational Site, Kingwood Texas
  • GSK Investigational Site, Uzhgorod
  • GSK Investigational Site, Leipzg Sachsen
  • GSK Investigational Site, Sandusky Ohio
  • GSK Investigational Site, Mar del Plata Buenos Aires
  • GSK Investigational Site, Barcelona
  • GSK Investigational Site, Dundee
  • GSK Investigational Site, San Ramon California
  • GSK Investigational Site, Wellington Florida
  • GSK Investigational Site, Kyiv
  • GSK Investigational Site, Chemnitz
  • GSK Investigational Site, Birmingham Alabama
  • GSK Investigational Site, Madrid
  • GSK Investigational Site, Wangen Baden-Wuerttemberg
  • GSK Investigational Site, Seoul
  • GSK Investigational Site, Getafe/Madrid
  • GSK Investigational Site, Kolbjørnsvik
  • GSK Investigational Site, Snellville Georgia
  • GSK Investigational Site, Stuhr Niedersachsen
  • GSK Investigational Site, Rättvik
  • GSK Investigational Site, Penndel Pennsylvania
  • GSK Investigational Site, København S
  • GSK Investigational Site, Berlin
  • GSK Investigational Site, Guadalajara Jalisco
  • GSK Investigational Site, BorÃ¥s
  • GSK Investigational Site, Northridge California
  • GSK Investigational Site, San Antonio Texas
  • GSK Investigational Site, Lima
  • GSK Investigational Site, Pittsburgh Pennsylvania
  • GSK Investigational Site, Gniewkowo
  • GSK Investigational Site, Frederiksberg
  • GSK Investigational Site, Jacksonville Florida
  • GSK Investigational Site, Stanford California
  • GSK Investigational Site, Herlev
  • GSK Investigational Site, Ciudad Autonoma de Buenos Aires Buenos Aires
  • GSK Investigational Site, Narbonne Cedex
  • GSK Investigational Site, Katowice
  • GSK Investigational Site, Tainan
  • GSK Investigational Site, Rocky Mount North Carolina
  • GSK Investigational Site, Columbia South Carolina
  • GSK Investigational Site, Wigan
  • GSK Investigational Site, UmeÃ¥
  • GSK Investigational Site, Esbjerg
  • GSK Investigational Site, Kemerovo
  • GSK Investigational Site, Bad Oeynhausen Nordrhein-Westfalen
  • GSK Investigational Site, Rapid City South Dakota
  • GSK Investigational Site, Berlin
  • GSK Investigational Site, Decatur Georgia
  • GSK Investigational Site, Strasbourg cedex
  • GSK Investigational Site, Dumfries
  • GSK Investigational Site, Hvidovre
  • GSK Investigational Site, St. Petersburg Florida
  • GSK Investigational Site, Rotherham
  • GSK Investigational Site, Magdeburg Sachsen-Anhalt
  • GSK Investigational Site, Wilmington North Carolina
  • GSK Investigational Site, Wenatchee Washington
  • GSK Investigational Site, Bad Kreuznach Rheinland-Pfalz
  • GSK Investigational Site, Halifax Nova Scotia
  • GSK Investigational Site, Dresden Sachsen
  • GSK Investigational Site, Krnov
  • GSK Investigational Site, Mannheim
  • GSK Investigational Site, Oschatz Sachsen
  • GSK Investigational Site, Elsterwerda Brandenburg
  • GSK Investigational Site, Athens,
  • GSK Investigational Site, Berlin
  • GSK Investigational Site, Schkeuditz Sachsen
  • GSK Investigational Site, Santiago de Compostela
  • GSK Investigational Site, Seoul
  • GSK Investigational Site, Statesville North Carolina
  • GSK Investigational Site, Camden New Jersey
  • GSK Investigational Site, Praha 10
  • GSK Investigational Site, Seoul
  • GSK Investigational Site, Seoul
  • GSK Investigational Site, Sudbury Ontario
  • GSK Investigational Site, Alpena Michigan
  • GSK Investigational Site, Ekaterinburg
  • GSK Investigational Site, Falkensee Brandenburg
  • GSK Investigational Site, Moscow
  • GSK Investigational Site, Elche
  • GSK Investigational Site, Ancona Marche
  • GSK Investigational Site, Ludwigshafen am Rhein Rheinland-Pfalz
  • GSK Investigational Site, Debrecen
  • GSK Investigational Site, Perm
  • GSK Investigational Site, Buenos Aires
  • GSK Investigational Site, Zlin
  • GSK Investigational Site, Dachau Bayern
  • GSK Investigational Site, Potsdam Brandenburg
  • GSK Investigational Site, Muenster Nordrhein-Westfalen
  • GSK Investigational Site, Stara Zagora
  • GSK Investigational Site, Vero Beach Florida
  • GSK Investigational Site, Madrid
  • GSK Investigational Site, S.Andrea delle Fratte - S. Sisto (PG) Umbria
  • GSK Investigational Site, Fife
  • GSK Investigational Site, Chula Vista California
  • GSK Investigational Site, Moscow
  • GSK Investigational Site, Fife
  • GSK Investigational Site, Vigevano (PV) Lombardia
  • GSK Investigational Site, Hualien
  • GSK Investigational Site, Atlanta Georgia
  • GSK Investigational Site, San Rafael Mendoza
  • GSK Investigational Site, Albuquerque New Mexico
  • GSK Investigational Site, Madrid
  • GSK Investigational Site, Pirna Sachsen
  • GSK Investigational Site, St-Charles-Borromée Quebec
  • GSK Investigational Site, Gyeonggi-do
  • GSK Investigational Site, Poznan
  • GSK Investigational Site, Vinnytsia
  • GSK Investigational Site, Copenhagen
  • GSK Investigational Site, Boadilla del Monte (Madrid)
  • GSK Investigational Site, Kyiv
  • GSK Investigational Site, San Diego California
  • GSK Investigational Site, Malaga
  • GSK Investigational Site, Brussels
  • GSK Investigational Site, Bradenton Florida
  • GSK Investigational Site, Portland Oregon
  • GSK Investigational Site, Córdoba
  • GSK Investigational Site, Madrid
  • GSK Investigational Site, Ciudad Autonoma de Buenos Aires Buenos Aires
  • GSK Investigational Site, Stockholm
  • GSK Investigational Site, Dresden Sachsen
  • GSK Investigational Site, Shatin
  • GSK Investigational Site, Aschaffenburg Bayern
  • GSK Investigational Site, Villingen-Schwenningen Baden-Wuerttemberg
  • GSK Investigational Site, Valencia
  • GSK Investigational Site, Soham Cambridgeshire
  • GSK Investigational Site, Aurora Illinois
  • GSK Investigational Site, Port Orange Florida
  • GSK Investigational Site, Madrid
  • GSK Investigational Site, Voronezh
  • GSK Investigational Site, Bydgoszcz
  • GSK Investigational Site, Sta Coloma de Gramanet (Barcelona)
  • GSK Investigational Site, San Martin de Porres Lima
  • GSK Investigational Site, Haidari, Athens
  • GSK Investigational Site, Bahia Blanca Buenos Aires
  • GSK Investigational Site, Chernivtsi
  • GSK Investigational Site, Lakeland Florida
  • GSK Investigational Site, Seoul
  • GSK Investigational Site, Nikaia Piraeus
  • GSK Investigational Site, Anderson South Carolina
  • GSK Investigational Site, Chesterfield Derbyshire
  • GSK Investigational Site, Eger
  • GSK Investigational Site, Ponte Verda Florida
  • GSK Investigational Site, Feasterville Pennsylvania
  • GSK Investigational Site, Freiburg Baden-Wuerttemberg
  • GSK Investigational Site, Louisville Kentucky
  • GSK Investigational Site, Heraklion, Crete
  • GSK Investigational Site, Granada
  • GSK Investigational Site, Long Beach California
  • GSK Investigational Site, Port Charlotte Florida
  • GSK Investigational Site, Lima
  • GSK Investigational Site, Ioannina
  • GSK Investigational Site, Seoul
  • GSK Investigational Site, Charlotte North Carolina
  • GSK Investigational Site, Chieti Abruzzo
  • GSK Investigational Site, Glendale Arizona
  • GSK Investigational Site, Chelyabinsk
  • GSK Investigational Site, Montana
  • GSK Investigational Site, Bruxelles
  • GSK Investigational Site, San Diego California
  • GSK Investigational Site, Dundee
  • GSK Investigational Site, Oakland California
  • GSK Investigational Site, Greenfield Indiana
  • GSK Investigational Site, Kingsport Tennessee
  • GSK Investigational Site, Salisbury North Carolina
  • GSK Investigational Site, Hong Kong
  • GSK Investigational Site, Omaha Nebraska
  • GSK Investigational Site, Palestine Texas
  • GSK Investigational Site, Santa Fe
  • GSK Investigational Site, Ryazan
  • GSK Investigational Site, Meppel
  • GSK Investigational Site, Ciudad Autonoma de Buenos Aires
  • GSK Investigational Site, Dresden Sachsen
  • GSK Investigational Site, Atlanta Georgia
  • GSK Investigational Site, Callao Lima
  • GSK Investigational Site, Liège
  • GSK Investigational Site, Ascoli Piceno Marche
  • GSK Investigational Site, Saratov
  • GSK Investigational Site, Roma Lazio
  • GSK Investigational Site, Arequipa
  • GSK Investigational Site, Manchester
  • GSK Investigational Site, Arlington Texas
  • GSK Investigational Site, Fleming Island Florida
  • GSK Investigational Site, Charlotte North Carolina
  • GSK Investigational Site, Gabrovo
  • GSK Investigational Site, Thessaloniki
  • GSK Investigational Site, Bydgoszcz
  • GSK Investigational Site, Haag Bayern
  • GSK Investigational Site, Kyiv
  • GSK Investigational Site, Leuven
  • GSK Investigational Site, Blackpool
  • GSK Investigational Site, Avon Indiana
  • GSK Investigational Site, Miskolc
  • GSK Investigational Site, Leipzig Sachsen
  • GSK Investigational Site, Suwon
  • GSK Investigational Site, Tempe Arizona
  • GSK Investigational Site, Stuttgart Baden-Wuerttemberg
  • GSK Investigational Site, Brampton Ontario
  • GSK Investigational Site, Apeldoorn
  • GSK Investigational Site, Ciudad Autónoma de Buenos Aires
  • GSK Investigational Site, Stuttgart Baden-Wuerttemberg
  • GSK Investigational Site, La Rochelle Cedex 1
  • GSK Investigational Site, St. Louis Missouri
  • GSK Investigational Site, Truro Nova Scotia
  • GSK Investigational Site, Thessaloniki
  • GSK Investigational Site, Taichung
  • GSK Investigational Site, Gueglingen Baden-Wuerttemberg
  • GSK Investigational Site, Berazategui
  • GSK Investigational Site, Monterrey Nuevo León
  • GSK Investigational Site, Albuquerque New Mexico
  • GSK Investigational Site, Novosibirsk
  • GSK Investigational Site, Karlskrona
  • GSK Investigational Site, Moscow
  • GSK Investigational Site, Little Rock Arkansas
  • GSK Investigational Site, Yaroslavl
  • GSK Investigational Site, Belle Glade Florida
  • GSK Investigational Site, Memphis Tennessee
  • GSK Investigational Site, Hamburg
  • GSK Investigational Site, Jersey Shore Pennsylvania
  • GSK Investigational Site, Newport Pennsylvania
  • GSK Investigational Site, Monterrey NL Nuevo León
  • GSK Investigational Site, Aberdeen
  • GSK Investigational Site, Lomita California
  • GSK Investigational Site, Federal Way Washington
  • GSK Investigational Site, Tacoma Washington
  • GSK Investigational Site, Ekaterinburg
  • GSK Investigational Site, Rostov-on-Don
  • GSK Investigational Site, Dallas Texas
  • GSK Investigational Site, St. Cloud Minnesota
  • GSK Investigational Site, Columbus Ohio
  • GSK Investigational Site, Levis Quebec
  • GSK Investigational Site, Edinburgh Midlothian
  • GSK Investigational Site, Hickory North Carolina
  • GSK Investigational Site, Hamburg
  • GSK Investigational Site, Kherson
  • GSK Investigational Site, Tomsk
  • GSK Investigational Site, Lima
  • GSK Investigational Site, Haddon Heights New Jersey
  • GSK Investigational Site, Lansdale Pennsylvania
  • GSK Investigational Site, Rosario Santa Fe
  • GSK Investigational Site, Changhua
  • GSK Investigational Site, Berlin
  • GSK Investigational Site, Kyiv
  • GSK Investigational Site, St. John's Newfoundland and Labrador
  • GSK Investigational Site, Edegem
  • GSK Investigational Site, Godoy Cruz Mendoza
  • GSK Investigational Site, GödöllÅ?
  • GSK Investigational Site, Taipei
  • GSK Investigational Site, Göteborg
  • GSK Investigational Site, Hamburg
  • GSK Investigational Site, Roeselare
  • GSK Investigational Site, Helsingborg
  • GSK Investigational Site, Ocala Florida
  • GSK Investigational Site, Mykolaiv
  • GSK Investigational Site, Pusan
  • GSK Investigational Site, Bergamo Lombardia
  • GSK Investigational Site, Sofia
  • GSK Investigational Site, San Sebastián de los Reyes/Madrid
  • GSK Investigational Site, Ciudad Autonoma de Buenos Aires Buenos Aires
  • GSK Investigational Site, Napoli Campania
  • GSK Investigational Site, Moscow
  • GSK Investigational Site, Härnösand
  • GSK Investigational Site, Sátoraljaújhely
  • GSK Investigational Site, Ravenna Emilia-Romagna
  • GSK Investigational Site, Yaroslavl
  • GSK Investigational Site, Ciudad Autonoma de Buenos Aires
  • GSK Investigational Site, Sneek
  • GSK Investigational Site, Frederikssund
  • GSK Investigational Site, Hellerup
  • GSK Investigational Site, Tucson Arizona
  • GSK Investigational Site, Gloucester
  • GSK Investigational Site, Buenos Aires
  • GSK Investigational Site, Rock Island Illinois
  • GSK Investigational Site, København NV
  • GSK Investigational Site, Moscow
  • GSK Investigational Site, Pireas
  • GSK Investigational Site, Seoul
  • GSK Investigational Site, Dundee
  • GSK Investigational Site, Bradenton Florida
  • GSK Investigational Site, Palma de Mallorca
  • GSK Investigational Site, Memphis Tennessee
  • GSK Investigational Site, Berlin
  • GSK Investigational Site, Spokane Washington
  • GSK Investigational Site, Bialystok
  • GSK Investigational Site, Napoli Campania
  • GSK Investigational Site, Hardenberg
  • GSK Investigational Site, Cambridge Ontario
  • GSK Investigational Site, El Paso Texas
  • GSK Investigational Site, San Juan (Alicante)
  • GSK Investigational Site, Poltava
  • GSK Investigational Site, New Port Richey Florida
  • GSK Investigational Site, Roma Lazio
  • GSK Investigational Site, Deggingen Baden-Wuerttemberg
  • GSK Investigational Site, Samara
  • GSK Investigational Site, Buenos Aires
  • GSK Investigational Site, Almeria
  • GSK Investigational Site, Dnipropetrovsk
  • GSK Investigational Site, Des Moines Iowa
  • GSK Investigational Site, Nashville Tennessee
  • GSK Investigational Site, Sofia
  • GSK Investigational Site, Mar del Plata Buenos Aires
  • GSK Investigational Site, Yaroslavl
  • GSK Investigational Site, Sevilla
  • GSK Investigational Site, Adrogue Buenos Aires
  • GSK Investigational Site, Miami Florida
  • GSK Investigational Site, Suite 101 Texas
  • GSK Investigational Site, Querétaro
  • GSK Investigational Site, Tomsk
  • GSK Investigational Site, Aguascalientes, Ags Aguascalientes
  • GSK Investigational Site, Alkmaar
  • GSK Investigational Site, Muncie Indiana
  • GSK Investigational Site, Buenos Aires
  • GSK Investigational Site, Guadalajara Jalisco
  • GSK Investigational Site, Oslo
  • GSK Investigational Site, Berlin
  • GSK Investigational Site, Malmö
  • GSK Investigational Site, Paris
  • GSK Investigational Site, Gouda
  • GSK Investigational Site, Pozuelo de Alarcón/Madrid
  • GSK Investigational Site, Madrid
  • GSK Investigational Site, Searcy Arkansas
  • GSK Investigational Site, Axbridge, Somerset
  • GSK Investigational Site, Kyiv
  • GSK Investigational Site, Kalamazoo Michigan
  • GSK Investigational Site, Seoul
  • GSK Investigational Site, Vandoeuvre-lès-Nancy
  • GSK Investigational Site, Smiths Falls Ontario
  • GSK Investigational Site, Berlin
  • GSK Investigational Site, Kaohsiung
  • GSK Investigational Site, Ivanovo
  • GSK Investigational Site, Komarom
  • GSK Investigational Site, Kleve Nordrhein-Westfalen
  • GSK Investigational Site, Lima
  • GSK Investigational Site, Catanzaro Calabria
  • GSK Investigational Site, Apeldoorn
  • GSK Investigational Site, Annapolis Maryland
  • GSK Investigational Site, Byala
  • GSK Investigational Site, Cangas del Narcea/Asturias
  • GSK Investigational Site, Tucson Arizona
  • GSK Investigational Site, Kyiv

Feature this Clinical Trial

Get your trial in front of 1000s of physicians and patients.
Visit ClinicalTrialsLocator.com to find out how you can feature this clinical trial.

Advertisement